ORCID Profile
0000-0002-3457-8770
Current Organisation
University of Adelaide
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Wiley
Date: 21-02-2017
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2018
Publisher: Springer Science and Business Media LLC
Date: 19-11-2018
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 08-04-2021
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 08-2017
DOI: 10.11124/JBISRIR-2016-003115
Abstract: The overall research objective of this scoping review is to determine the current evidence on frailty in nursing homes. The objectives of the scoping review are to map the following, as reported in international literature: Fraily tools used in studies on nursing home residents. Prevalence of frailty in nursing home residents. Geriatric syndromes (e.g. cognitive impairment, delirium, depression, falls, incontinence, malnutrition and dizziness) associated with frailty in nursing home residents. Other types of adverse outcomes related to frailty reported. Diverse treatment modalities of frailty in nursing home residents. The questions for the scoping review are: What frailty diagnostic tools have been reported in international literature that have been used in studies on nursing home residents? What prevalence rates of frailty in nursing home residents have been reported in the literature? What types of geriatric syndromes have been reported in the literature as being associated with frailty? What other types of adverse outcomes related to frailty have been reported in the literature? What treatment modalities for frailty have been reported in the literature?
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 03-2013
DOI: 10.1111/J.1744-1609.2012.00304.X
Abstract: Assistants have been utilised worldwide in healthcare as a means to ensure the provision of adequate and efficient healthcare in the midst of increased pressures on health services for many years. This review aimed to synthesise available qualitative evidence regarding the appropriateness of strategies used to establish the health assistant role as a recognised delegated clinical role and to promote their inclusion in models of care. This review focused on how to make strategies appropriate for health assistants and professionals. Health assistants were defined as those who provide assistance and support to health professionals by whom they are directly or indirectly supervised in all healthcare and health education sectors. A systematic review with meta-synthesis of qualitative studies using meta-aggregation was conducted. Types of participants considered included assistants in healthcare, including nursing and allied health assistants. The phenomena of interest was the appropriateness of strategies used to establish the assistant role as a recognised delegated clinical role and/or to promote their inclusion in models of care. Qualitative research studies including, but not limited to, designs such as phenomenology, grounded theory, ethnography, action research and feminist research were considered for inclusion. Electronic searches of multiple databases including MEDLINE, AMED, CINAHL and EMBASE, limited to the English language were conducted during the period of 14 April to 13 May 2011. In addition, grey literature was also searched for, as well as a hand search of relevant journals. Assessment of methodological quality of papers prior to inclusion in the review was performed using a standardised critical appraisal instrument from the Joanna Briggs Institute Qualitative Assessment and Review Instrument (JBI QARI). Data were extracted using the standardised data extraction tool from JBI QARI. Data synthesis using the JBI QARI approach of meta-synthesis by meta-aggregation was performed. Ten studies met the inclusion criteria. From the 10 included studies, 66 findings were identified that were organised into 11 categories by similarity of meaning. Categories were then aggregated into four synthesised findings: assistants and professionals may have good or difficult inter-professional relationships, which is dependent on a variety of factors, and can thus inform appropriate strategies to include assistants in models of care professionals and assistants perceive the assistant role and the need for practice change in different ways, whereas the role itself and tasks performed may be influenced by a number of different factors despite assistants feeling different levels of preparedness for training or the need for training, there are effective training programmes with certain characteristics that can result in positive training outcomes there are concerns amongst health staff regarding responsibility in models of care using assistants, highlighting the need for appropriate supervision and mentoring of assistants. Qualitative meta-synthesis was performed providing a unique perspective on the role of health assistants and strategies used to include them in models of care. These synthesised findings can be used to guide practice in healthcare organisations considering strategies for implementing the assistant role, or where assistants are currently utilised.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 12-2015
Publisher: Elsevier BV
Date: 2021
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 10-2017
DOI: 10.11124/JBISRIR-2016-003117
Abstract: The overall aim of this scoping review is to determine the optimal anthropometric variable parameters used to develop predictive equation(s) to estimate the components of body mass composition. The objectives of the scoping review are: To map the disparate international literature on the erse anthropometric variable parameters included in predictive equations for estimating the components of body mass composition. To map how research has been undertaken on the development of the anthropometric prediction equations for estimating the components of body mass composition. The questions for the scoping review are: What types of anthropometric variable parameters have been reported in the literature about the predictive equations used for estimating the components of body mass composition? What explanations or justifications have been reported in the literature for the inclusion of erse anthropometric variable parameters included in predictive equations used for estimating the components of body mass composition? What types of approaches have been reported in the literature for the development of predictive equations used for estimating the components of body mass composition?
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 2013
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 23-09-2019
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 10-2013
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 2010
Publisher: Elsevier BV
Date: 09-2013
DOI: 10.1016/J.IJCARD.2012.04.155
Abstract: Non-invasive methods based on applanation tonometry have been proposed to estimate central blood pressure. However, the accuracy of these methods hasn't been systematically examined. We performed a systematic review and meta-analysis of studies comparing estimated and invasively measured central BP. Sufficient data were available in 22 studies for meta-analysis (857 subjects and 1167 measurements). Acquired arterial pressure waveforms in these studies were directly measured, calibrated to match invasive aortic mean BP and diastolic BP or calibrated to match brachial BP measured with a sphygmomanometer, cuff BP. Of the former 2 conditions, the errors of estimated central BP were small with a mean and standard deviation of difference -1.1 ± 4.1mm Hg (95% limits of agreement -9.1-6.9 mm Hg) for central systolic BP -0.5 ± 2.1mm Hg (-4.6-3.6mm Hg) for central diastolic BP and -0.8 ± 5.1mm Hg (-10.8-9.2mm Hg) for central pulse pressure. However, the errors inflated to -8.2 ± 10.3mm Hg (-28.4-12.0mm Hg) for central systolic BP, 7.6 ± 8.7 mm Hg (-9.5-24.6mm Hg) for central diastolic BP, and -12.2 ± 10.4mm Hg (-32.5-8.1mm Hg) for central pulse pressure, when calibrated to cuff BP. The findings were still evident in subgroup analysis conducted with different central BP estimating methods and validated cuff BP monitors. Present tonometry-based central BP estimating methods are acceptable in theory, with small errors. However, based on current available evidence, there is substantial room for improvement in measurement accuracy of central BP when cuff BP is used to calibrate the peripheral waveforms.
Publisher: Elsevier BV
Date: 2019
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 11-2016
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 04-2019
DOI: 10.11124/JBISRIR-2017-003550
Abstract: The objective of the review is to examine Joanna Briggs Institute (JBI) qualitative meta-aggregative reviews to determine:
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2018
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 2011
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2015
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2015
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 05-2016
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 11-2018
DOI: 10.11124/JBISRIR-2017-003719
Abstract: The review question is: what is the best available evidence on the effectiveness of acupuncture as an adjunct treatment for women with postnatal depression?
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 10-2016
DOI: 10.11124/JBISRIR-2016-002948
Abstract: The objective of the review will be to identify, assess and synthesize the evidence that examines the magnitude and scope of disability including impairments, activity limitations and participation restrictions associated with four main non-communicable diseases (NCDs): cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases. To systematically examine the magnitude of disability associated with CVDs, cancers, diabetes and chronic lung diseases, the questions that this review will specifically address are: What is the prevalence of disability related to each of the four NCDs (presented by country and NCD where possible)? What is the prevalence of co-existing diseases/conditions (comorbidity) in persons with disabilities related to the four NCDs? To systematically examine the scope of disability associated with CVDs, cancers, diabetes and chronic respiratory diseases, the questions that this review will address are: What is the impact of disability on a person's life (measured using patient reported outcomes including quality of life measures)? What are the unmet needs in persons with disabilities related to the four NCDs?
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 06-2018
DOI: 10.11124/JBISRIR-2017-003520
Abstract: The objective of this review is to identify, evaluate and synthesize relevant research on the effectiveness of psychotherapies that engage Voice Hearers with their voices in order to change the person's quality of life, recovery, coping and distress. More specifically, the objective is to ascertain the effectiveness of this type of intervention with or without any other co-intervention, either pharmacological or non-pharmacological, compared to treatment as usual, for people from a Western or European culture aged 18–65 years who hear voices, regardless of ethnicity.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 2012
Publisher: Wiley
Date: 09-12-2021
DOI: 10.1002/HPJA.307
Publisher: Springer Science and Business Media LLC
Date: 15-06-2020
DOI: 10.1186/S13049-020-00749-2
Abstract: Over the last two decades, Emergency Department (ED) crowding has become an increasingly common occurrence worldwide. Crowding is a complex and challenging issue that affects EDs’ capacity to provide safe, timely and quality care. This review aims to map the research evidence provided by reviews to improve ED performance. We performed a scoping review, searching Cochrane Database of Systematic Reviews, Scopus, EMBASE, CINAHL and PubMed (from inception to July 9, 2019 prospectively registered in Open Science Framework osf.io/gkq4t/ ). Eligibility criteria were: (1) review of primary research studies, published in English (2) discusses a) how performance is measured in the ED, b) interventions used to improve ED performance and their characteristics, c) the role(s) of patients in improving ED performance, and d) the outcomes attributed to interventions used to improve ED performance (3) focuses on a hospital ED context in any country or healthcare system. Pairs of reviewers independently screened studies’ titles, abstracts, and full-texts for inclusion according to pre-established criteria. Discrepancies were resolved via discussion. Independent reviewers extracted data using a tool specifically designed for the review. Pairs of independent reviewers explored the quality of included reviews using the Risk of Bias in Systematic Reviews tool. Narrative synthesis was performed on the 77 included reviews. Three reviews identified 202 in idual indicators of ED performance. Seventy-four reviews reported 38 different interventions to improve ED performance: 27 interventions describing changes to practice and process (e.g., triage, care transitions, technology), and a further nine interventions describing changes to team composition (e.g., advanced nursing roles, scribes, pharmacy). Two reviews reported on two interventions addressing the role of patients in ED performance, supporting patients’ decisions and providing education. The outcomes attributed to interventions used to improve ED performance were categorised into five key domains: time, proportion, process, cost, and clinical outcomes. Few interventions reported outcomes across all five outcome domains. ED performance measurement is complex, involving automated information technology mechanisms and manual data collection, reflecting the multifaceted nature of ED care. Interventions to improve ED performance address a broad range of ED processes and disciplines.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 22-08-2019
DOI: 10.11124/JBISRIR-D-18-00010
Abstract: The objective of this review was to synthesize the best available evidence on the effectiveness and harms of pharmacological interventions for the treatment of delirium in adult patients in the intensive care unit (ICU) after cardiac surgery. Patients who undergo cardiac surgery are at high risk of delirium (incidence: 50–90%). Delirium has deleterious effects, increasing the risk of death and adversely affecting recovery. Clinical interventional trials have been conducted to prevent and treat postoperative delirium pharmacologically including antipsychotics and sedatives. These trials have provided some evidence about efficacy and influenced clinical decision making. However, much reporting is incomplete and provides biased assessments of efficacy benefits are emphasized while harms are inadequately reported. Participants were ≥ 16 years, any sex or ethnicity, who were treated postoperatively in a cardiothoracic ICU following cardiac surgery and were identified as having delirium. Any pharmacological intervention for the treatment of delirium was included, regardless of drug classification, dosage, intensity or frequency of administration. Outcomes of interest of this review were: mortality, duration and severity of delirium, use of physical restraints, quality of life, family members’ satisfaction with delirium management, duration/severity of the aggressive episode, associated falls, severity of accidental self-harm, pharmacological harms, harms related to over-sedation, ICU length of stay, hospital length of stay (post ICU), total hospital length of stay, need for additional intervention medication and need for rescue medication. Randomized controlled trials were considered first and in their absence, non-randomized controlled trials and quasi-experimental would have been considered, followed by analytical observational studies. A search was conducted in PubMed, Embase, CINAHL, Web of Science, Cochrane Central Register of Controlled Trials, Scopus, Epistemonikos, Australian New Zealand Clinical Trials Registry, ClinicalTrials.gov, Clinical Trials in New Zealand, and ProQuest Dissertations and Theses to locate both published and unpublished studies. There was no date limit for the search. A hand search for primary studies published between January 1, 2012 and November 17, 2018 in relevant journals was also conducted. Only studies published in English were considered for inclusion. Two reviewers independently assessed the methodological quality using standardized critical appraisal instruments from JBI and McMaster University. Quantitative data were extracted using the standardized JBI data extraction tool. A meta-analysis was not performed, as there was too much clinical and methodological heterogeneity in the included studies. Results have been presented in a narrative form. Standard GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) evidence assessment of outcomes has been reported. Three RCTs investigating morphine versus haloperidol (n = 53), ondansetron versus haloperidol (n = 72), and dexmedetomidine versus midazolam (n = 80) were included. Due to heterogeneity and incomplete reporting, a meta-analysis was not feasible. Overall, the methodological quality of these studies was found to be low. Additionally, this review found reporting of harms to be inadequate and superficial for all three studies and did not meet the required standards for harms reporting, as defined by the CONSORT statement extension for harms. It was not possible to draw any valid conclusions regarding the effectiveness of morphine vs haloperidol, ondansetron vs haloperidol or dexmedetomidine vs midazolam in treating delirium after cardiac surgery. This is due to the low number of studies, the poor methodological quality in conducting and reporting and the heterogeneity between the studies.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 10-2017
DOI: 10.11124/JBISRIR-2016-003324
Abstract: The objective of the scoping review is to map the international scientific literature on web-based therapeutic interventions (WBTI) used by Indigenous people for assessing, managing and treating health conditions. The focus of this review is WBTIs for a broad range of health conditions, including but not limited to, communicable and non-communicable diseases, mental health conditions (including the broader concept of social and emotional wellbeing), use of harmful substances and gambling. The questions for the scoping review are: 1. What types of WBTI used for assessing, managing and treating health conditions in Indigenous populations have been reported in the literature? 2. What conclusions and interpretations with regards to the uptake and the effects of WBTI used for assessing, managing and treating health conditions in Indigenous populations have been reported in the literature? 3. What recommendations for practice with regards to the use of WBTI for assessing, managing and treating health conditions in Indigenous populations have been reported in the literature? 4. What explanations have been reported in the literature for the observed uptake of WBTI used for assessing, managing and treating health conditions in Indigenous populations? 5. What types of outcomes have been reported in the literature for the use of WBTI for assessing, managing and treating health conditions in Indigenous populations? 6. What explanations have been reported in the literature for the observed outcomes of WBTI used for assessing, managing and treating health conditions in Indigenous populations?
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 10-2017
Publisher: American Medical Association (AMA)
Date: 12-2013
Publisher: Oxford University Press (OUP)
Date: 28-01-2014
DOI: 10.1093/AJH/HPT282
Abstract: Oscillometric central blood pressure (CBP) monitors have emerged as a new technology for blood pressure (BP) measurements. With a newly proposed diagnostic threshold for CBP, we investigated the diagnostic performance of a novel CBP monitor. We recruited a consecutive series of 138 subjects (aged 30-93 years) without previous use of antihypertensive agents for simultaneous invasive and noninvasive measurements of BP in a catheterization laboratory. With the cutoff (CBP ≥130/90 mm Hg) for high blood pressure (HBP), the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the novel CBP monitor were calculated with reference to the measured CBP. In comparison, the diagnostic performance of the conventional cuff BP was also evaluated. The noninvasive CBP for detecting HBP in a s le with a prevalence of 52% showed a sensitivity of 93% (95% confidence interval (CI) = 91-95), specificity of 95% (95% CI = 94-97), PPV of 96% (95% CI = 94-97), and NPV of 93% (95% CI = 90-95). In contrast, with cuff BP and the traditional HBP criterion (cuff BP ≥140/90 mm Hg), the sensitivity, specificity, PPV, and NPV were 49% (95% CI = 44-53), 94% (95% CI = 92-96), 90% (95% CI = 86-93), and 63% (95% CI 59-66), respectively. A stand-alone oscillometric CBP monitor may provide CBP values with acceptable diagnostic accuracy. However, with reference to invasively measured CBP, cuff BP had low sensitivity and NPV, which could render possible management inaccessible to a considerable proportion of HBP patients, who may be identifiable through noninvasive CBP measurements from the CBP monitor.
Publisher: Wiley
Date: 09-04-2020
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 2012
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 2017
DOI: 10.11124/JBISRIR-2016-003021
Abstract: The scoping review project will identify and describe the existing research on health promotion programs and activities focusing on modifying risk factors (specifically to reduce smoking and alcohol consumption, increase physical activity and improve nutrition and social and emotional wellbeing) and/or improving the management of chronic diseases (specifically obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease) for Aboriginal and Torres Strait Islander peoples across a erse range of health and community settings.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 12-2017
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 04-2017
Publisher: BMJ
Date: 16-09-2015
DOI: 10.1136/BMJ.H4320
Abstract: To reanalyse SmithKline Beecham's Study 329 (published by Keller and colleagues in 2001), the primary objective of which was to compare the efficacy and safety of paroxetine and imipramine with placebo in the treatment of adolescents with unipolar major depression. The reanalysis under the restoring invisible and abandoned trials (RIAT) initiative was done to see whether access to and reanalysis of a full dataset from a randomised controlled trial would have clinically relevant implications for evidence based medicine. Double blind randomised placebo controlled trial. 12 North American academic psychiatry centres, from 20 April 1994 to 15 February 1998. 275 adolescents with major depression of at least eight weeks in duration. Exclusion criteria included a range of comorbid psychiatric and medical disorders and suicidality. Participants were randomised to eight weeks double blind treatment with paroxetine (20-40 mg), imipramine (200-300 mg), or placebo. The prespecified primary efficacy variables were change from baseline to the end of the eight week acute treatment phase in total Hamilton depression scale (HAM-D) score and the proportion of responders (HAM-D score ≤8 or ≥50% reduction in baseline HAM-D) at acute endpoint. Prespecified secondary outcomes were changes from baseline to endpoint in depression items in K-SADS-L, clinical global impression, autonomous functioning checklist, self-perception profile, and sickness impact scale predictors of response and number of patients who relapse during the maintenance phase. Adverse experiences were to be compared primarily by using descriptive statistics. No coding dictionary was prespecified. The efficacy of paroxetine and imipramine was not statistically or clinically significantly different from placebo for any prespecified primary or secondary efficacy outcome. HAM-D scores decreased by 10.7 (least squares mean) (95% confidence interval 9.1 to 12.3), 9.0 (7.4 to 10.5), and 9.1 (7.5 to 10.7) points, respectively, for the paroxetine, imipramine and placebo groups (P=0.20). There were clinically significant increases in harms, including suicidal ideation and behaviour and other serious adverse events in the paroxetine group and cardiovascular problems in the imipramine group. Neither paroxetine nor high dose imipramine showed efficacy for major depression in adolescents, and there was an increase in harms with both drugs. Access to primary data from trials has important implications for both clinical practice and research, including that published conclusions about efficacy and safety should not be read as authoritative. The reanalysis of Study 329 illustrates the necessity of making primary trial data and protocols available to increase the rigour of the evidence base.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 2012
Publisher: Springer Science and Business Media LLC
Date: 31-05-2020
DOI: 10.1186/S13643-020-01374-X
Abstract: Barriers to receiving optimal healthcare exist for Indigenous populations globally for a range of reasons. To overcome such barriers and enable greater access to basic and specialist care, developments in information and communication technologies are being applied. The focus of this scoping review is on web-based therapeutic interventions (WBTI) that aim to provide guidance, support and treatment for health problems. This review identifies and describes international scientific evidence on WBTI used by Indigenous peoples in Australia, New Zealand, Canada and USA for managing and treating a broad range of health conditions. Studies assessing WBTI designed for Indigenous peoples in Australia, Canada, USA and New Zealand, that were published in English, in peer-reviewed literature, from 2006 to 2018 (inclusive), were considered for inclusion in the review. Studies were considered if more than 50% of participants were Indigenous, or if results were reported separately for Indigenous participants. Following a four-step search strategy in consultation with a research librarian, 12 databases were searched with a view to finding both published and unpublished studies. Data was extracted, synthesised and reported under four main conceptual categories: (1) types of WBTI used, (2) community uptake of WBTI, (3) factors that impact on uptake and (4) conclusions and recommendations for practice. A total of 31 studies met the inclusion criteria. The WBTI used were interactive websites, screening and assessment tools, management and monitoring tools, gamified avatar-based psychological therapy and decision support tools. Other sources reported the use of mobile apps, multimedia messaging or a mixture of intervention tools. Most sources reported moderate uptake and improved health outcomes for Indigenous people. Suggestions to improve uptake included as follows: tailoring content and presentation formats to be culturally relevant and appropriate, customisable and easy to use. Culturally appropriate, evidence-based WBTI have the potential to improve health, overcome treatment barriers and reduce inequalities for Indigenous communities. Access to WBTI, alongside appropriate training, allows health care workers to better support their Indigenous clients. Developing WBTI in partnership with Indigenous communities ensures that these interventions are accepted and promoted by the communities.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2015
Publisher: BMJ
Date: 14-10-2015
DOI: 10.1136/BMJ.H5412
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 03-2019
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 11-2018
DOI: 10.11124/JBISRIR-2017-003923
Abstract: The purpose of this methodological review is to determine whether and to what extent GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methodology has been and is currently being used in Australian clinical practice guidelines.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 08-2018
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 07-2014
Location: Australia
No related grants have been discovered for CATALIN TUFANARU.